- Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer
-
Park YJ, Koh EH, Kim J, Roh JK, Chang J, Ahn CM, Sohn HY, Kim SK, Lee WY, Kim K, Suh CO, Kim GE, Loh JJ, Kim BS
- KMID: 1118127
- Yonsei Med J.
- 1989 Mar;30(1):30-37.
- doi: 10.3349/ymj.1989.30.1.30
The development of drug resistance is the major limiting factor influencing the survival of patients with small cell lung cancer (SCLC). We have thus examined the activity of cyclophosphamide, doxorubicin... -
- CITED
-
- Close
- SHARE
-
- Close
